Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort.
Leo-Hansen C, Faurholt-Jepsen D, Qvist T, Højte C, Nielsen BU, Bryrup T, Henriksen EH, Katzenstein T, Skov M, Mathiesen IHM, Jeppesen M, Jensen-Fangel S, Olesen HV, Buchvald FF, Nielsen KG, Jimenez-Solem E, Ritz C, Pressler T, Olsen MF; TransformCF Study Group. Leo-Hansen C, et al. ERJ Open Res. 2024 Dec 9;10(6):00339-2024. doi: 10.1183/23120541.00339-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39655171 Free PMC article.
Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.
Bryrup T, Faurholt-Jepsen D, Pressler T, Henriksen EH, Leo-Hansen C, Nielsen BU, Højte C, Mathiesen IHM, Katzenstein TL, Jeppesen M, Jensen-Fangel S, Olesen HV, Skov M, Qvist T, Olsen MF; TransformCF Study Group. Bryrup T, et al. Among authors: leo hansen c. APMIS. 2024 Oct;132(10):728-733. doi: 10.1111/apm.13453. Epub 2024 Aug 2. APMIS. 2024. PMID: 39092470
Change in exercise capacity measured by Cardio-pulmonary Exercise Testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with Lumacaftor/Ivacaftor and Tezacaftor/Ivacaftor.
Rysgaard UK, Pedersen CL, Jensen JH, Sørensen L, Philipsen LKD, Leo-Hansen C, Olesen HV. Rysgaard UK, et al. Among authors: leo hansen c. J Cyst Fibros. 2022 Sep;21(5):844-849. doi: 10.1016/j.jcf.2022.05.009. Epub 2022 Jun 3. J Cyst Fibros. 2022. PMID: 35667973 Free article.
Glucometabolic changes influence hospitalization and outcome in patients with COVID-19: An observational cohort study.
Clausen CL, Leo-Hansen C, Faurholt-Jepsen D, Krogh-Madsen R, Ritz C, Kirk O, Jørgensen HL, Benfield T, Almdal TP, Snorgaard O. Clausen CL, et al. Among authors: leo hansen c. Diabetes Res Clin Pract. 2022 May;187:109880. doi: 10.1016/j.diabres.2022.109880. Epub 2022 Apr 25. Diabetes Res Clin Pract. 2022. PMID: 35483546 Free PMC article.
Afri-Can Forum 2 : Johannesburg, South Africa. 16-18 February 2015.
Mukudu H, Martinson N, Sartorius B, Coetzee J, Dietrich J, Mokgatswana K, Jewkes R, Gray GE, Dugas M, Béhanzin L, Guédou FA, Gagnon MP, Alary M, Rutakumwa R, Mbonye M, Kiwanuka T, Nakamanya S, Muhumuza R, Nalukenge W, Seeley J, Atujuna M, Wallace M, Brown B, Bekker LG, Newman PA, Harryparsad R, Olivier AJ, Jaspan HB, Wilson D, Dietrich J, Martinson N, Mukudu H, Mkhize N, Morris L, Cianci G, Dinh M, Hope T, Passmore JAS, Gray CM, Henrick BM, Yao XD, Rosenthal KL; the INFANT Study Team; Henrick BM, Yao XD, Drannik AG, Abimiku A, Rosenthal KL; the INFANT Study Team; Chanzu N, Mwanda W, Oyugi J, Anzala O, Mbow M, Jallow S, Thiam M, Davis A, Diouf A, Ndour CT, Seydi M, Dieye TN, Mboup S, Goodier M, Rilley E, Jaye A, Yao XD, Omange RW, Henrick BM, Lester RT, Kimani J, Ball TB, Plummer FA, Rosenthal KL, Béhanzin L, Guédou FA, Geraldo N, Mastétsé EG, Sossa JC, Zannou MD, Alary M, Osawe S, Okpokoro E, Okolo F, Umaru S, Abimiku R, Audu S, Datong P, Abimiku A, Nyange J, Olenja J, Mutua G, Jaoko W, Omosa-Manyonyi G, Farah B, Khaniri M, Anzala O, Cockcroft A, Tonkin K, Girish I, Mhati P, Cunningham A, Andersson N, Farah B, Indangasi J, Jaoko W, Mutua G, Khaniri M, Nyange J, Anzala O, Diphoko T… See abstract for full author list ➔ Mukudu H, et al. Among authors: leo hansen c. BMC Infect Dis. 2016 Jul 12;16 Suppl 2(Suppl 2):315. doi: 10.1186/s12879-016-1466-6. BMC Infect Dis. 2016. PMID: 27410689 Free PMC article.
Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau.
Román VR, Jensen KJ, Jensen SS, Leo-Hansen C, Jespersen S, da Silva Té D, Rodrigues CM, Janitzek CM, Vinner L, Katzenstein TL, Andersen P, Kromann I, Andreasen LV, Karlsson I, Fomsgaard A. Román VR, et al. Among authors: leo hansen c. AIDS Res Hum Retroviruses. 2013 Nov;29(11):1504-12. doi: 10.1089/AID.2013.0076. Epub 2013 Jun 21. AIDS Res Hum Retroviruses. 2013. PMID: 23634822 Clinical Trial.
Clade A HIV-1 Gag-specific T cell responses are frequent but do not correlate with viral loads in a cohort of treatment-naive HIV-infected individuals living in Guinea-Bissau.
Jensen KJ, Gómez Román VR, Jensen SS, Leo-Hansen C, Karlsson I, Katzenstein TL, Rodrigues CM, Jespersen S, Janitzek CM, Té Dda S, Hayes P, Fomsgaard A. Jensen KJ, et al. Among authors: leo hansen c. Clin Vaccine Immunol. 2012 Dec;19(12):1999-2001. doi: 10.1128/CVI.00399-12. Epub 2012 Oct 17. Clin Vaccine Immunol. 2012. PMID: 23081817 Free PMC article. No abstract available.
Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervals.
Gómez Román VR, Jensen SS, Leo-Hansen C, Jensen KJ, Janitzek CM, Rodrigues CM, Jespersen S, Katzenstein TL, Té Dda S, Fomsgaard A. Gómez Román VR, et al. Among authors: leo hansen c. Clin Vaccine Immunol. 2012 Aug;19(8):1322-5. doi: 10.1128/CVI.00170-12. Epub 2012 Jun 6. Clin Vaccine Immunol. 2012. PMID: 22675154 Free PMC article.